Novavax | The Business Standard
Skip to main content
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা
The Business Standard
MONDAY, MARCH 01, 2021
MONDAY, MARCH 01, 2021
  • Home
  • Economy
  • Analysis
  • Bangladesh
  • World
  • Sports
  • Glitz
  • Feature
  • Long Read
  • PSI
  • Games
  • epaper
  • More
    • COVID-19
    • Top News
    • Companies
    • Environment
    • Infograph
    • Interviews
    • Markets
    • Special Stories
    • Multimedia/videos
    • Offbeat
    • Panorama
    • Thoughts
    • Science
    • Splash
    • Tech
    • Subscribe
    • Archive
  • বাংলা

Novavax

Coronavirus chronicle

Fresh data show toll South African virus variant takes on vaccine efficacy

The vaccines from Novavax Inc and Johnson & Johnson were significantly less effective at preventing Covid-19 in trial participants in South Africa, where the potent new variant is widespread...

Coronavirus chronicle

J&J vaccine adds to Covid-19 armoury, includes South African variant

Coronavirus chronicle

Novavax says Covid-19 vaccine 89% effective in UK trial, less in South Africa

Coronavirus chronicle

India's Serum says made 40 million doses of AstraZeneca's Covid vaccine, to make Novavax shot soon

Coronavirus chronicle

Novavax CEO expects filing for Covid-19 vaccine approval in December: paper

Coronavirus chronicle

Novavax begins mid-stage study of Covid-19 vaccine in South Africa

Coronavirus chronicle

Takeda to make Novavax's Covid-19 vaccine candidate in Japan

Coronavirus chronicle

Novavax reports promising early trial results of Covid-19 vaccine

Coronavirus chronicle

US awards $1.6 billion to Novavax for COVID-19 vaccine

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - [email protected]

For advertisement- [email protected]

Copyright © 2021 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab